Lisa V. DeLuca
Consigliere Generale presso GLYCOMIMETICS, INC.
Profilo
Lisa V.
DeLuca is currently the Vice President-Regulatory Affairs at GlycoMimetics, Inc. She previously worked as the Director-Regulatory Affairs at AstraZeneca Pharmaceuticals LP, Principal at Wyeth LLC, Manager-Regulatory Affairs at Centocor, Inc., Principal at The Upjohn Co., Vice President-Regulatory Affairs at NewLink Genetics Corp., Vice President-Global Regulatory Affairs at Eximias Pharmaceutical Corp., Vice President-Regulatory Affairs at Celator Pharmaceuticals, Inc., Vice President-Regulatory Affairs at Topaz Pharmaceuticals, Inc., Vice President-Global Regulatory Affairs at YM Biosciences USA, Inc., and Senior Vice President-Regulatory Affairs at Nuvation Bio, Inc. Dr. DeLuca obtained her undergraduate and graduate degrees from Eastern Michigan University and her doctorate from the University of Toledo (Ohio).
Posizioni attive di Lisa V. DeLuca
| Società | Posizione | Inizio |
|---|---|---|
| GLYCOMIMETICS, INC. | Consigliere Generale | 22/11/2021 |
Precedenti posizioni note di Lisa V. DeLuca
| Società | Posizione | Fine |
|---|---|---|
| LUMOS PHARMA, INC. | Consigliere Generale | 01/07/2018 |
| CELATOR PHARMACEUTICALS INC | Consigliere Generale | 01/08/2016 |
| NUVATION BIO INC. | Consigliere Generale | - |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | - |
| The Upjohn Co. | Corporate Officer/Principal | - |
Formazione di Lisa V. DeLuca
| University of Toledo (Ohio) | Doctorate Degree |
| Eastern Michigan University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| NUVATION BIO INC. | Health Technology |
| GLYCOMIMETICS, INC. | Health Technology |
| Aziende private | 9 |
|---|---|
Eximias Pharmaceutical Corp.
 Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Eximias Pharmaceutical Corp. develops pharmaceuticals for treatment of cancer disorders. It offers its services in the mid-Atlantic areas. The company is headquartered in Berwyn, PA. | Health Technology |
YM Biosciences USA, Inc.
 YM Biosciences USA, Inc. Pharmaceuticals: MajorHealth Technology YM Biosciences USA, Inc. develops and commercializes pharmaceutical products. The company was founded on November 23, 2005 and is headquartered in Wayne, PA. | Health Technology |
Topaz Pharmaceuticals, Inc.
 Topaz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Topaz Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on developing and commercializing treatments for the pediatric and dermatology markets. Its lead investigational product is a topical cream formulation of ivermectin which is under development. The firm provides medicines for the treatment of head lice, acne and infections, as well as vaccines against childhood diseases. The company was founded by Donald P. Beeman and Nicholas U. Spring in 2005 and is headquartered in Horsham, PA. | Health Technology |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
| The Upjohn Co. | Health Technology |
Celator Pharmaceuticals, Inc.
 Celator Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Celator Pharmaceuticals, Inc. engages in the research and development of biopharmaceutical products. The company was founded by Lawrence David Mayer, and Marcel B. Bally in 1999 and is headquartered in Ewing, NJ. | Health Technology |
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
- Borsa valori
- Insiders
- Lisa V. DeLuca
